Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2006 Mar 15;173(6):659-66.
doi: 10.1164/rccm.200410-1369OC. Epub 2005 Dec 30.

Risk factors for death of patients with cystic fibrosis awaiting lung transplantation

Richard A Belkin  1 , Noreen R Henig, Lianne G Singer, Cecilia Chaparro, Ronald C Rubenstein, Sharon X Xie, Justin Y Yee, Robert M Kotloff, David A Lipson, Greta R Bunin
Affiliations
Comparative Study

Risk factors for death of patients with cystic fibrosis awaiting lung transplantation

Richard A Belkin et al. Am J Respir Crit Care Med. .

Abstract

Rationale: The optimal timing for listing of cystic fibrosis patients for lung transplantation is controversial.

Objectives: We conducted a retrospective cohort study of 343 patients listed for lung transplantation at four academic medical centers to identify risk factors for death while awaiting transplantation.

Methods: Data on possible risk factors were abstracted from medical records.

Measurements: Time to death, patient demographic characteristics, and risk factors for death while awaiting transplantation were assessed. Univariate and multivariate survival analyses were performed using Cox regression.

Results: By univariate analyses, FEV1 < or = 30% predicted (HR, 3.8; 95% CI, 2.0-7.5), Pa(CO2) > or = 50 mm Hg (HR, 1.85; 95% CI, 1.1-3.0), and shorter height (HR, 1.8; 95% CI, 1.1-3.0) were associated with a higher risk of death. Referral from an accredited cystic fibrosis center was associated with a lower risk (HR, 0.53; 95% CI, 0.30-0.92). The final multivariate model included referral from an accredited cystic fibrosis center (HR, 0.5; 95% CI, 0.3-1.0) and listing year after 1996 (HR, 0.4; 95% CI, 0.2-0.7); both were associated with a lower risk of death. FEV1 < or = 30% predicted (HR, 6.8; 95% CI, 2.4-19.3), Pa(CO2) > or = 50 mm Hg (HR, 6.9; 95% CI, 1.5-32.1), and use of a nutritional intervention (HR, 2.3; 95% CI, 1.3-4.1) were associated with increased risk. Patients with FEV1 > 30% predicted had a higher risk of death only when their Pa(CO2) was > or = 50 mm Hg (HR, 7.0; 95% CI, 1.5-32), while the increased risk of death with FEV1 < or = 30% was not further influenced by the presence of hypercapnia.

Conclusions: We identified risk factors for waiting list mortality that could impact on transplant listing and allocation guidelines.

PubMed Disclaimer

Figures

<b>Figure 1.</b>
Figure 1.
Kaplan-Meier survival plot of the proportion of patients with cystic fibrosis awaiting lung transplantation, based on a cutoff in FEV1 of 30% predicted. The p value from the log-rank test is less than 0.01. Solid line, FEV1 > 30% predicted; dashed line, FEV1 ⩽ 30% predicted.
See this image and copyright information in PMC

References

    1. Charman SC, Sharples LD, McNeil KD, Wallwork J. Assessment of survival benefit after lung transplantation by patient diagnosis. J Heart Lung Transplant 2002;21:226–232. - PubMed
    1. Zuckerman JB, Kotloff RM. Lung transplantation for cystic fibrosis [review]. Clin Chest Med 1998;19:535–554, vii. - PubMed
    1. Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992;326:1187–1191. - PubMed
    1. Arcasoy SM, Kotloff RM. Lung transplantation. N Engl J Med 1999;340:1081–1091. - PubMed
    1. Geller DE, Kaplowitz H, Light MJ, Colin AA; Scientific Advisory Group, Investigators, and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics. Chest 1999;116:639–646. - PubMed

Publication types